Company overview
Basic information
Company name
Balfarma, UAB
Company code
126067950
VAT code
LT260679515
Registered address
Vilnius, Architektų g. 89-14, LT-04207
Registration date
2002-10-15
Company age: 23 y. 11 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
UAB "Balfarma"
Company code: 126067950
Address: Vilnius, Architektų g. 89-14, LT-04207
VAT code: LT260679515
Download a detailed company report
Make confident decisions with all the information about Balfarma, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Balfarma, UAB (company code 126067950) is a private limited liability company registered in 2002 and operating in Vilnius, at Architektu g. 89-14, Vilniaus m. sav., Vilniaus apskr. The company is operational, privately owned, and belongs to the sector of national private non-financial companies. Its governance is described as CEO only. Balfarma carries out retail sale of pharmaceutical products under EVRK code G.47.73.00. The company is classified as micro-sized and has authorised capital of EUR 2.9K.
The most recent financial figures provided are for 2024, when revenue was EUR 1.7K, compared with EUR 3.4K in 2023. Net loss was EUR 1.4K in 2024 after a EUR 2.1K loss in 2023, and the profit margin remained negative. Equity was negative at EUR 6.8K, while liabilities increased to EUR 7.7K. Total assets stood at EUR 832. Staff levels were stable, with an average of 1 employee in 2023, 2024 and 2025.
The most recent financial figures provided are for 2024, when revenue was EUR 1.7K, compared with EUR 3.4K in 2023. Net loss was EUR 1.4K in 2024 after a EUR 2.1K loss in 2023, and the profit margin remained negative. Equity was negative at EUR 6.8K, while liabilities increased to EUR 7.7K. Total assets stood at EUR 832. Staff levels were stable, with an average of 1 employee in 2023, 2024 and 2025.